Buy Tirzepatide (Tirz Max) in South Africa
Tirz Max by Dex Pharma is a pharmaceutical-grade formulation of Tirzepatide — a dual GLP-1 and GIP receptor agonist clinically validated for significant body-weight reduction and improved glycemic control. Peak Protocol stocks Tirz Max in South Africa with ZAR pricing, batch-traceable vials and cold-chain courier shipping nationwide.
- Dual GLP-1 + GIP agonist — superior fat loss vs single GLP-1s.
- Strong appetite suppression and insulin sensitivity benefits.
- Once-weekly subcutaneous protocol.
- 99%+ purity, third-party verified.
- Discreet packaging, EFT and card checkout in ZAR.
What is Tirzepatide?
Tirzepatide is a once-weekly injectable peptide that activates both the GLP-1 and GIP receptors. It is the active compound behind Mounjaro and Zepbound, approved internationally for type 2 diabetes and chronic weight management. Phase 3 SURMOUNT trial data reported mean weight-loss outcomes of up to 22.5% of body weight at the highest dose at 72 weeks.
Why buy Tirz Max from Peak Protocol
- Authentic Dex Pharma stock — sealed vials, batch-traceable.
- ZAR pricing — no hidden FX or import surprises.
- Cold-chain courier to all major SA metros in 2–3 business days.
- Protocol guidance and reconstitution support on request.
- Discreet packaging, EFT or card checkout.
FAQs
Is Tirz Max the same as Tirzepatide?
Yes — Tirz Max is Dex Pharma's pharmaceutical-grade Tirzepatide, supplied in lyophilized vials for subcutaneous reconstitution.
Is this the same compound as Mounjaro?
The active peptide is the same (Tirzepatide). Dex Pharma supplies it as a research-grade vial rather than a branded auto-injector, which keeps ZAR pricing accessible.
How does Tirzepatide compare to Retatrutide?
Tirzepatide is a dual GLP-1/GIP agonist with strong real-world data. Retatrutide adds a third receptor (glucagon) and shows even higher fat-loss outcomes in trials — but is newer. Compare to Reta Max.
Looking for the full range? Browse all Dex Pharma products or shop the Dex Pharma catalog.